Trials / Completed
CompletedNCT00264953
HD11 for Intermediate Stages
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,395 (actual)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to (1) compare the efficacy of the BEACOPP regimen with that of ABVD as a 4-cycle chemotherapy combined with an involved field irradiation and (2) to define the optimum radiation dose comparing of 30 to 20 Gy in the same context.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adriamycin | |
| DRUG | Bleomycin | |
| DRUG | Vinblastine | |
| DRUG | DTIC | |
| DRUG | Etoposide | |
| DRUG | Procarbazine | |
| DRUG | Prednisone | |
| DRUG | Vincristine | |
| RADIATION | radiation therapy | 20 or 30Gy IF-RT |
Timeline
- Start date
- 1998-05-01
- Primary completion
- 2003-01-01
- First posted
- 2005-12-13
- Last updated
- 2011-08-04
Source: ClinicalTrials.gov record NCT00264953. Inclusion in this directory is not an endorsement.